The relationship was observed with both “brakes” and “accelerators” of cancer-immune response, consistent with a dysfunctional T-cell–inflamed TME21,22, where the infiltration of CD8 + cells and interferon-gamma secretion can upregulate local negative immunoregulatory mechanisms that reduce T-cell effector function34,35. This evidence concerns the gene IFNG and cancer.